Is ResMed (NYSE:RMD) Using Too Much Debt?
BDX Stock Down Despite New Expansion to Boost Fingertip Blood Testing
With 74% Institutional Ownership, ResMed Inc. (NYSE:RMD) Is a Favorite Amongst the Big Guns
We Ran A Stock Scan For Earnings Growth And ResMed (NYSE:RMD) Passed With Ease
This AutoZone Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Stifel Maintains ResMed(RMD.US) With Hold Rating, Maintains Target Price $250
ResMed Analyst Ratings
Zacks.com Featured Highlights Include InterDigital, ResMed, Greenbrier Companies, Charles River Associates and Kontoor Brands
Stifel Initiates ResMed(RMD.US) With Hold Rating, Announces Target Price $250
ResMed Launches Head Strap for Apple's Vision Pro System
RMD or PODD: Which Is the Better Value Stock Right Now?
5 Solid Dividend Growth Stocks to Buy Now
Scoop Up These 3 GARP Stocks to Receive Handsome Returns
ResMed Inc. (NYSE:RMD) Shares Could Be 29% Below Their Intrinsic Value Estimate
Returns on Capital Paint A Bright Future For ResMed (NYSE:RMD)
ResMed (RMD) Rose 15% in Q3
ResMed Inc Director Plans Strategic Share Sale
PDCO Stock Gains Despite Q2 Earnings Miss and Lower Margins
Will HAE Stock Gain Following Sell-Off of Whole Blood Assets to GVS?
Canada Sleep Apnea Devices Market Research Report 2024: Opportunities and Forecasts to 2029 Featuring Braebon Medical, VitalAire, FPM Solutions, SomnoMed, and ResMed